To do so, we analysed HER-1–4 and ligand NRG1 mRNA expression pattern in breast cancer and normal breast tissue and correlated findings to ER mRNA expression (ESR1) and plasma, normal tissue and breast cancer tissue estrogen levels previously determined [17,18]. The gene discussed is ESR1; the disease is breast carcinoma.